Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 6/26/15 → 6/26/18 |
Funding
- PRA Health Sciences (Prot #ACE-ST-003)
- Acerta Pharma, LLC (Prot #ACE-ST-003)
Prot #ACE-ST-003: A Phase 2 Proof-of-Concept Study of ACP-196 Alone and in Combination with Pembrolizumab in Subjects with Advanced or Metastatic Pancreatic Cancer
- Benson III, Al B (PD/PI)
Project: Research project